Registry for Pulmonary Hypertension Due to Left Heart Disease in China

Chinese Academy of Medical Sciences, Fuwai Hospital

Status: Unknown

Conditions: Pulmonary Hypertension Due to Left Heart Disease

Treatments: Other: Routine therapy

Study type: Observational

Funder types: Other

Identifiers

NCT02164526

CRPHDLHD

Details and patient eligibility

About

Left heart disease is the main cause of pulmonary hypertension. With the advent of the aging society, chronic heart failure has become a global public health problem. Therefore the prevalence of pulmonary hypertension due to the left heart disease is increasing. However, there is no research on the prevalence of pulmonary hypertension due to the left heart disease in China. Therefore, the aim of the present study was to describe real-world outcome of Chinese patients with pulmonary hypertension due to the left heart disease and identify factors that may predict outcome. Our study will profile the demographics, clinical course, treatments, and outcomes of pulmonary hypertension due to the left heart disease in China.

Enrollment: 520 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pulmonary Hypertension due to left heart disease

Exclusion criteria

• Other forms of Pulmonary Hypertension
• Heart failure due to valvular heart disease
• Hypertrophic obstructive cardiomyopathy
• Right ventricular outflow tract stenosis
• Pericardial disease
• Patients with chronic lung disease

Trial design

520 participants in 1 patient group

No treatment

Treatment:

Other: Routine therapy